Viewing Study NCT01561794


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-03-02 @ 10:05 PM
Study NCT ID: NCT01561794
Status: COMPLETED
Last Update Posted: 2015-04-27
First Post: 2012-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pneumonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ciprofloxacin View
None Bacterial pneumonia View
None Community Acquired Pneumonia (CAP) View
None Hospital Acquired Pneumonia (HAP) View
None Secondary infection of chronic respiratory disease View
None 400 mg BID/TID View